Suresh Mahabhashyam
Technik-/Wissenschafts-/F&E-Leiter bei CORVUS PHARMACEUTICALS, INC.
Aktive Positionen von Suresh Mahabhashyam
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CORVUS PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 | - |
Karriereverlauf von Suresh Mahabhashyam
Ehemalige bekannte Positionen von Suresh Mahabhashyam
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | 01.01.2019 |
| ALEXION PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 | 01.01.2015 |
Ausbildung von Suresh Mahabhashyam
| Bangalore Medical College & Research Institute | Doctorate Degree |
| University of North Texas Health Science Center | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Indien | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| CORVUS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Suresh Mahabhashyam
- Erfahrung
